Veracyte, Inc.
VCYT
$32.13
$1.203.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 704.79% | 26.28% | -117.09% | 478.06% | 118.07% |
| Total Depreciation and Amortization | -15.27% | -10.41% | -4.34% | -4.08% | -1.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -96.13% | 54.91% | 126.59% | -17.76% | -52.87% |
| Change in Net Operating Assets | 242.43% | 7,110.99% | -78.87% | 32.61% | -369.52% |
| Cash from Operations | 114.41% | 49.37% | 13.63% | 159.80% | 57.69% |
| Capital Expenditure | 8.72% | -24.53% | 53.57% | 14.76% | -65.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.39% | -- | -- | -- | -- |
| Cash from Investing | 89.97% | 2,252.68% | 91.91% | -1,900.49% | -2,068.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.54% | -53.56% | 40.40% | -0.03% | 84.20% |
| Repurchase of Common Stock | -11.76% | -29.08% | -82.66% | -146.63% | -190.51% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 96.70% | -71.07% | -5,045.45% | -650.46% | -799.22% |
| Foreign Exchange rate Adjustments | 102.99% | -58.90% | 1,039.34% | 168.52% | -235.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 236.17% | 151.75% | 24.89% | -648.81% | -346.68% |